Literature DB >> 20534790

Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.

Ichiro Matsunari1, Hirofumi Aoki, Yusuke Nomura, Nozomi Takeda, Wei-Ping Chen, Junichi Taki, Kenichi Nakajima, Stephan G Nekolla, Seigo Kinuya, Kouji Kajinami.   

Abstract

BACKGROUND: Although both (123)I-metaiodobenzylguanidine ((123)I-MIBG) imaging and (11)C-hydroxyephedrine ((11)C-HED) positron emission tomography (PET) are used for assessing cardiac sympathetic innervation, their relationship remains unknown. The aims were to determine whether (123)I-MIBG parameters such as heart-to-mediastinum ratio (H/M) are associated with quantitative measures by (11)C-HED PET and to compare image quality, defect size, and location between (123)I-MIBG single-photon emission computed tomography (SPECT) and (11)C-HED PET. METHODS AND
RESULTS: Twenty-one patients (mean left ventricular ejection fraction, 39 ± 15%) underwent (123)I-MIBG imaging and (11)C-HED PET. Early (15-minute), late (3-hour) H/M, and washout rate (WR) were calculated for (123)I-MIBG. Myocardial retention and WR was calculated for (11)C-HED. Using a polar map approach, defect was defined as the area with relative activity <60% of the maximum. Both the early (r=0.76) and late (r=0.84) (123)I-MIBG H/M were correlated with (11)C-HED retention. (123)I-MIBG WR was correlated with (11)C-HED WR (r=0.57). Defect size could not be measured in 3 patients because of poor quality (123)I-MIBG SPECT, whereas (11)C-HED defect was measurable in all patients. Although defect size measured by early or late (123)I-MIBG SPECT was closely correlated with that by (11)C-HED PET (early: r=0.94; late: r=0.88), the late (123)I-MIBG overestimated defect size particularly in the inferior and septal regions.
CONCLUSIONS: (123)I-MIBG H/M gives a reliable estimate of cardiac sympathetic innervation as measured by (11)C-HED PET. Furthermore, despite the close correlation in defect size, (11)C-HED PET appears to be more suitable for assessing regional abnormalities than does (123)I-MIBG SPECT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534790     DOI: 10.1161/CIRCIMAGING.109.920538

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  25 in total

1.  Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.

Authors:  Berlinda J van der Veen; Imad Al Younis; Albert de Roos; Marcel P M Stokkel
Journal:  J Nucl Cardiol       Date:  2012-06-06       Impact factor: 5.952

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  I-123 metaiodobenzylguanidine innervation imaging as a tool for norepinephrine transporter research: A possible application for genetic analysis in heart failure.

Authors:  Kenichi Nakajima; Ichiro Matsunari; Arnold F Jacobson
Journal:  J Nucl Cardiol       Date:  2016-11-28       Impact factor: 5.952

Review 4.  Cardiac autonomic innervation.

Authors:  Hina K Jamali; Fahad Waqar; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2016-11-14       Impact factor: 5.952

Review 5.  Cardiac molecular imaging to track left ventricular remodeling in heart failure.

Authors:  Jamshid Shirani; Amitoj Singh; Sahil Agrawal; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2016-08-01       Impact factor: 5.952

6.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 7.  Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.

Authors:  Shuchita Gupta; Aman Amanullah
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 8.  Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging.

Authors:  Nabil E Boutagy; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

9.  Impact of obesity and acquisition protocol on (123)I-metaiodobenzylguanidine indexes of cardiac sympathetic innervation.

Authors:  Teresa Pellegrino; Valentina Piscopo; Antonio Boemio; Barbara Russo; Gianluca De Matteis; Sara Pellegrino; Sara Maria Delle Acque Giorgio; Manuela Amato; Mario Petretta; Alberto Cuocolo
Journal:  Quant Imaging Med Surg       Date:  2015-12

10.  LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment.

Authors:  Ming Yu; Jody Bozek; Melanie Lamoy; Mikhail Kagan; Pedro Benites; David Onthank; Simon P Robinson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.